Elutia
ELUT0.82310.51% ( -0.0042 )
Elutia (ELUT)
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The...
- Open
- 0.8200
- High
- 0.8346
- Low
- 0.7901
- Prev. Close
- 0.8273
- Volume
- 19.73K
- Turnover
- 15.91K
- Avg Price
- 0.8068
- Bid/Ask Ratio
- 0.00%
- Amplitude
- 5.38%
- 52wk High
- 1.3850
- Volume Ratio
- 0.30
- Turnover Ratio
- 0.07%
- 52wk Low
- 0.5000
- Float Mkt Cap
- 24.27M
- Market CapUSD
- 36.45M
- P/ETTM
- 0.70
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- 1.17
- EPSDynamic
- -0.683
- EPSStatic
- --
- BVPS
- 0.36
- P/B
- 2.32
- Circulating Supply
- 29.48M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 44.29M
- Min lot size
- 1
- Currency
- USD
Elutia Analyst Rating
View moreForecast & Rating
Oct 5, 2026Price forecast
$5.00507.46%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Global Report ·
Biotech Underdogs' Equity Gambit as Wall Street Eyes Double-Digit Upside
- benzinga_article ·
12 Health Care Stocks Moving In Friday's Pre-Market Session
- StockTitan ·
Elutia Receives $8 Million Payment from Boston Scientific; Company Now Fully Funded into 2029 | ELUT Stock News
- benzinga_article ·
12 Health Care Stocks Moving In Thursday's After-Market Session
